Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sarah B. Goldberg"'
Autor:
Nikolaus Schultz, Edward B. Garon, Maria E. Arcila, Michelle DeVeaux, Scott N. Gettinger, Zongzhi Liu, Katerina Politi, Christine A. Lydon, Anna Wurtz, Andrew J. Plodkowski, Gregory J. Riely, A. Truini, Hira Rizvi, J. Killam, Helena A. Yu, Wei Wei, Daniel Zelterman, Niamh Long, Isabel B. Oliva, Sarah B. Goldberg, Roy S. Herbst, Jungmin Choi, M. Ladanyi, Francisco Sanchez-Vega, Aaron Lisberg, Darragh Halpenny, Matthew D. Hellmann, Katherine Hastings, Guoping Cai, B.S. Henick, Mark M. Awad
Publikováno v:
Annals of Oncology
Background Although EGFR mutant tumors exhibit low response rates to immune checkpoint blockade overall, some EGFR mutant tumors do respond to these therapies; however, there is a lack of understanding of the characteristics of EGFR mutant lung tumor
Autor:
James C. Moon, Karen Kelly, Zenta Walther, Roy S. Herbst, Mary Ann Melnick, David R. Gandara, Sarah B. Goldberg, Katerina Politi, Fred R. Hirsch, Mary W. Redman, Philip C. Mack
Publikováno v:
Journal of Clinical Oncology. 38:9532-9532
9532 Background: ctDNA from patient plasma has demonstrated diagnostic utility in non-small cell lung cancer (NSCLC). Longitudinal changes in mutant allele frequency (MAF) have great potential to refine clinical management on targeted therapies. Meth
Autor:
Karen Kelly, S. Mashru, David R. Gandara, Scott N. Gettinger, Leora Horn, Mary W. Redman, James Moon, Mary Ann Melnick, Sarah B. Goldberg, Rogerio Lilenbaum, Jieling Miao, T. Stinchcombe, Katerina Politi, Everett H. Chen
Publikováno v:
Journal of Thoracic Oncology. 13:S343-S344
Autor:
George R. Simon, Paul A. Bunn, Alice T. Shaw, Sarah B. Goldberg, Robert C. Doebele, Daniel Morgensztern, David R. Spigel, Roy S. Herbst, Thomas A. Hensing, Charles M. Rudin, David E. Gerber, Suresh S. Ramalingam, Neeta Somaiah, John Wrangle, Meghan Campo, Ramaswamy Govindan, Lecia V. Sequist, Peter S. Hammerman, Edward B. Garon, Rebecca S. Heist, David H. Johnson, Leora Horn, Ravi Salgia, Suzanne E. Dahlberg
Publikováno v:
Journal of Thoracic Oncology. 10:S1-S63
There have been significant advances in the understanding of the biology and treatment of non-small cell lung cancer (NSCLC) over the past few years. A number of molecularly targeted agents are in the clinic or in development for patients with advanc
Autor:
Philip Brohawn, Niels Reinmuth, Paul Baas, David Vicente, Kazuhiko Nakagawa, Sarah B. Goldberg, Myung-Ju Ahn, U. Scheuring, Scott J. Antonia, Ki Hyeong Lee, Byoung Chul Cho, Manuel Cobo Dols, F. Liu, Vladimir Moiseyenko, Naiyer A. Rizvi, Alexander Luft, Alexey Smolin, Solange Peters, Edward J. Kim, Delyth Clemett, P. Thiyagarajah, Rajiv Raja
Publikováno v:
Cancer Research. 79:CT074-CT074
Background High TMB is predictive of PFS benefit with anti-PD-(L)1 ± anti-CTLA-4 therapy in mNSCLC. Preliminary results from MYSTIC (NCT02453282), an open-label, Phase III trial of first-line durvalumab (D; anti-PD-L1), ± tremelimumab (T; anti-CTLA
Autor:
Ranjan Pathak, Daniel J. Boffa, Andres F. Monsalve, Benjamin J. Resio, Jessica R. Hoag, Sarah B. Goldberg
Publikováno v:
Journal of Clinical Oncology. 37:8519-8519
8519 Background: The role of adjuvant chemotherapy (AC) in stage IB (pT2aN0) and IIA (pT2bN0) non-small cell lung cancer (NSCLC) is currently unclear. Existing guideline recommendations are inconsistent, ranging from all tumors >4 cm, to any patient
Autor:
Adam J. Kole, Daniel J. Boffa, Roy H. Decker, Nicholas Carriero, Abhijit A. Patel, Sameer K. Nath, Roxanne Nemati, Sarah B. Goldberg, J. Teysir, Katerina Politi, Roy S. Herbst, Scott N. Gettinger, Lynn D. Wilson, Shrikant Mane, Azeet Narayan, Alfred Ian Lee, Daniel Zelterman, Yanhong Deng, Nitin Sukumar
Publikováno v:
Annals of Oncology. 28:v478
Publikováno v:
Surgical oncology clinics of North America. 22(2)
The standard treatment of limited-stage small cell lung cancer (SCLC) is concurrent cisplatin and etoposide with thoracic radiation therapy, whereas treatment of extensive-stage disease is typically chemotherapy alone with a platinum compound plus et
Autor:
Anne C. Chiang, Alexander O. Vortmeyer, Veronica Chiang, Elin Rowen, Xiaopan Yao, Heather Gerrish, Sarah B. Goldberg, Lucia B. Jilaveanu, Harriet M. Kluger, Matthew Madura, Stephanie Speaker, A. John Tsiouris, Roy S. Herbst, Scott N. Gettinger, Amit Mahajan, Elizabeth Knapp-Perry
Publikováno v:
Journal of Clinical Oncology. 33:8035-8035
8035 Background: Brain metastases (BrMs) are common among patients (pts) with advanced non-small cell lung cancer (NSCLC) and local therapy such as surgery and radiation can add toxicity and delay ...
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 90:S58